These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10619190)

  • 1. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.
    Coruzzi G; Adami M; Coppelli G; Frati P; Soldani G
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):715-8. PubMed ID: 10619190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach.
    Adami M; Frati P; Bertini S; Kulkarni-Narla A; Brown DR; de Caro G; Coruzzi G; Soldani G
    Br J Pharmacol; 2002 Apr; 135(7):1598-606. PubMed ID: 11934799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats.
    Germanò MP; D'Angelo V; Mondello MR; Pergolizzi S; Capasso F; Capasso R; Izzo AA; Mascolo N; De Pasquale R
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):241-4. PubMed ID: 11218077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
    Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
    Smith SR; Terminelli C; Denhardt G
    J Pharmacol Exp Ther; 2000 Apr; 293(1):136-50. PubMed ID: 10734163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways.
    Fukuda H; Abe T; Yoshihara S
    Int Arch Allergy Immunol; 2010; 152(3):295-300. PubMed ID: 20150748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
    Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH; Oriowo MA
    Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data.
    Coruzzi G; Adami M; Guaita E; Menozzi A; Bertini S; Giovannini E; Soldani G
    Dig Dis Sci; 2006 Feb; 51(2):310-7. PubMed ID: 16534674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis.
    Gross A; Terraza A; Marchant J; Bouaboula M; Ouahrani-Bettache S; Liautard JP; Casellas P; Dornand J
    J Leukoc Biol; 2000 Mar; 67(3):335-44. PubMed ID: 10733093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
    Burgos E; Pascual D; Martín MI; Goicoechea C
    Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
    Sánchez C; de Ceballos ML; Gomez del Pulgar T; Rueda D; Corbacho C; Velasco G; Galve-Roperh I; Huffman JW; Ramón y Cajal S; Guzmán M
    Cancer Res; 2001 Aug; 61(15):5784-9. PubMed ID: 11479216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
    Cui YY; D'Agostino B; Risse PA; Marrocco G; Naline E; Zhang Y; Chen HZ; Finance O; Rinaldi-Carmona M; Rossi F; Advenier C
    Eur J Pharmacol; 2007 Nov; 573(1-3):206-13. PubMed ID: 17643417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-alpha production by human mononuclear cells.
    Germain N; Boichot E; Advenier C; Berdyshev EV; Lagente V
    Int Immunopharmacol; 2002 Mar; 2(4):537-43. PubMed ID: 11962732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric antisecretory effects of synthetic cannabinoids after central or peripheral administration in the rat.
    Adami M; Zamfirova R; Sotirov E; Tashev R; Dobrinova Y; Todorov S; Coruzzi G
    Brain Res Bull; 2004 Dec; 64(4):357-61. PubMed ID: 15561471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q; Bhat M; Bowen WD; Cheng J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
    Griffin G; Wray EJ; Tao Q; McAllister SD; Rorrer WK; Aung MM; Martin BR; Abood ME
    Eur J Pharmacol; 1999 Jul; 377(1):117-25. PubMed ID: 10448934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.
    Pakdeechote P; Dunn WR; Ralevic V
    Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.